Clinical Trial Update: Pilot Study Comparing Treatment With Dexmedetomidine to Midazolam for Symptom Control in Advanced Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 pilot trial comparing dexmedetomidine to midazolam for symptom control in advanced cancer patients was withdrawn. The study status is WITHDRAWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Dexmedetomidine (Precedex) (dexmedetomidine)
• Midazolam (Versed) (Midazolam)

Snippet

Sponsor: Fraser Health | Conditions: Pain Intractable, Delirium | Phase 2 | Status: WITHDRAWN